Tetravalent Rabies-Vectored Filovirus and Lassa Fever Vaccine Induces Long-term Immunity in Nonhuman Primates.
Drishya KurupChristine R FisherGabrielle ScherCatherine YankowskiAnnaMarie TestaRohan KeshwaraTiago Abreu-MotaRachael LambertMelissa FergusonWilliam RinaldiLeonard RuizChristoph WirblichMatthias J SchnellPublished in: The Journal of infectious diseases (2022)
In summary, this study shows the longevity of the immune responses up to 365 days for a pentavalent vaccine-against Ebola virus, Sudan virus, Marburg virus, Lassa virus, and RABV-using a safe and effective vaccine platform.